First experience of pancreaticoduodenectomy using Revo-i in a patient with insulinoma.

Authors :: Kang I
Hwang HK
Lee WJ
Kang CM
Source :: Annals of hepato-biliary-pancreatic surgery [Ann Hepatobiliary Pancreat Surg] 2020 Feb; Vol. 24 (1), pp. 104-108. Date of Electronic Publication: 2020 Feb 27.
Publication Year :: 2020
Abstract: Robotic surgery systems have been developed to overcome the limitations of laparoscopic surgery. Recently, Meerecompany Inc. in Korea successfully manufactured a robotic surgical system called Revo-i. A 65-year old woman was referred for a pancreatic head tumor, detected as an incidental finding during a routine check-up. Contrast abdominopelvic CT revealed a pancreatic uncinate tumor measuring around 13 mm in diameter, with no other focal lesions. The patient underwent a robot-assisted pancreaticoduodenectomy (laparoscopic resection and robotic reconstruction) using Revo-i. The patient's recovery was uneventful and discharged on postoperative day 7. Our case showed the technical feasibility of the Korean robotic surgical system Revo-i. Further experiences are mandatory to validate this finding.<br />Competing Interests: CONFLICT OF INTEREST: Currently, the second clinical trial of Revo-i in advanced minimally invasive surgery is undergoing supported by meeraecompany research fund (research No. 1-2019-0030).<br /> (Copyright © 2020 by The Korean Association of Hepato-Biliary-Pancreatic Surgery.)

Full Text Access

Tools